A portfolio of essential medicines
Lorazepam Xilmac
Dosages and presentations
LORAZÉPAM XILMAC 4mg/ml.
Solution for injection.
Box of 10 vials.
Product information - Patient information leaflet
Active ingredient
Lorazepam
Marketing
France
Product news
Product available
This information is intended for healthcare professionals.
Our therapeutic areas
and our main products
Infectiology
Amikacin
Aztreonam
Amoxicillin
Xyllomac®
(France)
Amoxicillin Delbert®
(Ireland)
Delamoxyle®
(Belgium - Luxembourg)
Delamoxyl®
(Switzerland)
Amoxicillin and clavulanic acid
Benzathine benzylpenicillin
Extencilline®
(France - Switzerland)
Extencin®
(Netherlands)
Benzylpenicillin benzathine
(United Kingdom)
Oxacillin
Istopen®
(France)
Penstapho®
(Italy)
Prostaphlin®
(Czech Republic)
Central nervous system
Lithium carbonate
Tropatépine hydrochloride
Pipotiazine palmitic ester
Lorazepam
Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.
REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT
To request medical information on Delbert Pharma products or report an adverse event,
please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.

